Pasar al contenido principal

COMPETENCIA APOPTOTICA CONTRA PATOGENOS

PID2020-119031RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

  • González-Montero, María-Cristina
  • Andrés-Rodríguez, Julia
  • Criado, Miguel
  • Andrés, Sonia
  • Galli, Giulio
  • Fernández-Rubio, Celia
  • Pérez-Pertejo, Yolanda
  • Reguera, Rosa M.
  • Balaña-Fouce, Rafael
  • García-Estrada, Carlos
This article belongs to the Special Issue Organoid Models in Host–Pathogen Interactions and Disease Pathogenesis, [Institutional Review Board Statement] The animal study protocol was approved by the Ethics Committee of the University of León, protocol code OEBA-ULE-010-2023, in compliance with Spanish and EU legislation (RD 53/2013 and 2010/63/EU, approved on 14 April 2023)., The development of new alternative models is essential to overcome the limitations of traditional two-dimensional (2D) cell cultures and animal models. Three-dimensional (3D) models, such as organoids, better mimic the structural and functional complexity of mammalian organs, thereby reducing the ethical and economic issues related to animal experimentation. These systems provide more physiologically relevant environments, improving the accuracy of disease modeling and drug response prediction. In this context, we have developed mouse hepatic organoids from livers of adult BALB/c mice and characterized them by microscopy and transcriptional analysis. This model was applied to a robust and reproducible high-throughput screening (HTS) platform for testing cytotoxicity at the preclinical stage of drug discovery. In addition, mouse hepatic organoids were co-cultured with amastigotes of Leishmania donovani parasites to establish a model of host–parasite interaction, which was characterized by RNA-seq linked to differential expression analysis and cytokine production by the hepatic organoids. The findings provided in this work establish mouse hepatic organoids as an alternative model for drug discovery and pathogenesis studies., This research was funded by projects PID2020-119035RB-I00, PID2020-119031RB-I00, PID2021-126489OB-I00, funded by Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033, “FEDER, Una manera de hacer Europa”, and HaloSheep (Agroecological sheep/goat production system based on the valorization of halophytes of saline areas in the Mediterranean basin) funded under the PRIMA Programme by the European Union (NextGenerationEU) and Ministerio de Ciencia, Innovación y Universidades (PCI2022-132925). G.G. received Grant PRE2021-096909 funded by MICIU/AEI/10.13039/501100011033 and by “ESF Investing in your future”. M.-C.G.-M. received a PhD fellowship from Universidad de León., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An Immunocompetent Hepatic Organoid Model Reveals Conserved Hepatic Immune Dysregulation During Leishmania donovani Infection

  • González-Montero, María-Cristina
  • Criado, Miguel
  • Fernández-Rubio, Celia
  • Pérez-Pertejo, Yolanda
  • Reguera, Rosa M
  • Balaña-Fouce, Rafael
  • García-Estrada, Carlos
33 páginas, 10 figuras, 7 tablas., Visceral leishmaniasis, caused by Leishmania donovani, is characterized by profound alterations in hepatic immune responses that promote parasite persistence. However, the lack of physiologically relevant in vitro systems limits investigation of tissue-level host-pathogen interactions. An immunocompetent three-dimensional hepatic organoid model incorporating bone marrow-derived macrophages was established to investigate liver-stage immune responses to L. donovani infection. Integrated cytokine profiling and transcriptomic analyses were benchmarked against infected mouse liver tissue. Macrophages acquired functional characteristics consistent with a Kupffer cell-like phenotype and contributed to immune homeostasis within the co-culture. Infection induced a conserved immune response characterized by inflammatory and chemotactic activation. This response was accompanied by coordinated suppression of antimicrobial pathways, including the IL-12-IFN-γ axis and interferon-stimulated genes. These immune alterations were largely shared between the organoid model and infected liver tissue, although systemic metabolic reprogramming and multicellular complexity were not fully recapitulated. Our findings identify a conserved pattern of hepatic immune dysregulation in which inflammatory activation is uncoupled from effective antimicrobial signaling, potentially facilitating parasite persistence. This immunocompetent hepatic organoid platform provides a physiologically relevant system for investigating host-pathogen interactions and evaluating host-directed therapeutic strategies for visceral leishmaniasis., This research was funded by Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033, “FEDER, Una manera de hacer Europa”, grant numbers PID2020- 119035RB-I00 and PID2020-119031RB-I00. M.-C.G.-M. received a PhD fellowship from Universidad de León, Peer reviewed